Research Study

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study Of Benralizumab in Patients With Severe Nasal Polyposis
Principal Investigator 
Arif Janjua

Overview

Body Locations and Systems 
Nose Injuries and Disorders
ClinicalTrials.gov# 
NCT03401229
Status 
Closed for Recruitment
Study Start/End 
May 23, 2018 to Feb 12, 2020
Locations 
Diamond Health Care Centre
Name/Title 
Philzah Othman, Research Coordinator
Purpose of Study 

The purpose of this study is test the efficacy and safety of Benralizumab in patients with severe nasal polyposis.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.